{
    "2020-07-27": [
        [
            {
                "time": "",
                "original_text": "互动]贝达药业：在研新药BPI-D0316开展的一线、二线研究均有序推进中",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "BPI-D0316",
                        "新药研发",
                        "一线研究",
                        "二线研究"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "从隐秘到胜出，解码红杉医疗投资版图",
                "features": {
                    "keywords": [
                        "红杉资本",
                        "医疗投资",
                        "投资策略",
                        "行业布局"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "投资"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}